Some Common Heart Medications Linked To ‘Modest’ Cancer Risk Increase
June 14, 2010
According to the researchers, there is an increase in prostate, breast and lung cancer of 1 in every 105 people taking angiotensin-receptor blockers (ARBs).
Of those diagnoses, there was an especially significant increase in lung cancer.
Millions of people globally take ARBs for high blood pressure and heart failure, and they have become an important part of dealing with heart conditions.
But in 2003, some correlations were found between those patients who took them, and a risk of cancer. The latest study was to find out how important and severe that risk was.
The data used showed 68,000 current patient records with cancer, 61,000 new patient records with cancer, and 93,000 cancer-related deaths.
However, Dr Ilke Sipahi, the study’s leader, says that the risk may not outweigh the benefits of the drugs.
“My message for the patients who are currently on ARBs is they should not stop taking these medications on their own because they have beneficial effects. They need to make a decision with their physicians about the potential risks and whether they need to switch.”
The study has been published in The Lancet Oncology.